Latest News

August 06, 2012
Scientists at the UCSF-affiliated Gladstone Institutes have discovered that an FDA-approved anti-epileptic drug reverses memory loss and alleviates other Alzheimer’s-related impairments in an animal model of the disease.
July 25, 2012
Raising levels of the neurotransmitter dopamine in the frontal cortex of the brain significantly decreased impulsivity in healthy adults, in a study conducted by researchers at the Ernest Gallo Clinic and Research Center at the University of California, San Francisco.
May 24, 2012
UCSF has received a challenge gift of $20 million from the Sandler Foundation that will provide major support for the university’s groundbreaking research and clinical care efforts regarding neurological diseases.
May 20, 2012
UCSF scientists have shown that a key brain structure in the Bengalese finch acts as a learning hub, receiving information that helps to improve its song, a finding which may lead to new ways to treat neurological disorders that impair movement such as Parkinson’s disease.
May 03, 2012
UCSF scientists have identified patterns of brain activity in the rat brain that play a role in the formation and recall of memories and decision-making. The discovery, which builds on the team’s previous findings, offers a path for studying learning, decision-making and post-traumatic stress syndrome.
April 26, 2012
Scientists at the Gladstone Institutes have unraveled a process by which depletion of a specific protein in the brain contributes to the memory problems associated with Alzheimer’s disease. These findings provide insights into the disease’s development and may lead to new therapies that could benefit the millions of people worldwide.
October 24, 2011
A study by researchers at the University of Mississippi Medical Center and UCSF shows that rats given a popularly prescribed antidepressant during development exhibit brain abnormalities and behaviors characteristic of autism spectrum disorders.
October 14, 2011
The only medication currently approved for stroke treatment – tissue plasminogen activator (tPA), which dissolves blood clots – is associated with an increased risk of bleeding in the brain, particularly among patients with hyperglycemia (high blood sugar).
September 28, 2011
Brain tumor specimens taken from neurosurgery cases at the University of California, San Francisco (UCSF) Medical Center has given scientists a new window on the transformation that occurs as healthy brain cells begin to form tumors
September 26, 2011
Gallo neuroscientist Linda Wilbrecht, PhD, receives President’s Early Career Award, in recognition of her studies on the effects of drug use and stress on the adolescent brain, aimed at developing strategies to mitigate drug dependence.

Pages